Your browser doesn't support javascript.
loading
MLKL Requires the Inositol Phosphate Code to Execute Necroptosis.
Dovey, Cole M; Diep, Jonathan; Clarke, Bradley P; Hale, Andrew T; McNamara, Dan E; Guo, Hongyan; Brown, Nathaniel W; Cao, Jennifer Yinuo; Grace, Christy R; Gough, Peter J; Bertin, John; Dixon, Scott J; Fiedler, Dorothea; Mocarski, Edward S; Kaiser, William J; Moldoveanu, Tudor; York, John D; Carette, Jan E.
Affiliation
  • Dovey CM; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Diep J; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Clarke BP; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
  • Hale AT; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
  • McNamara DE; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Guo H; Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health Sciences Center, San Antonio, TX 78229, USA.
  • Brown NW; Department of Chemistry, Princeton University, Princeton, NJ 08544, USA; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.
  • Cao JY; Department of Biology, Stanford University, Stanford, CA 94305, USA.
  • Grace CR; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Gough PJ; Host Defense Discovery Performance Unit, Infectious Diseases Therapy Area Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.
  • Bertin J; Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, PA 19426, USA.
  • Dixon SJ; Department of Biology, Stanford University, Stanford, CA 94305, USA.
  • Fiedler D; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.
  • Mocarski ES; Department of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Kaiser WJ; Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health Sciences Center, San Antonio, TX 78229, USA.
  • Moldoveanu T; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • York JD; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
  • Carette JE; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: carette@stanford.edu.
Mol Cell ; 70(5): 936-948.e7, 2018 06 07.
Article in En | MEDLINE | ID: mdl-29883610
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Kinases / Colonic Neoplasms / Inositol Phosphates Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Cell Journal subject: BIOLOGIA MOLECULAR Year: 2018 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein Kinases / Colonic Neoplasms / Inositol Phosphates Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Cell Journal subject: BIOLOGIA MOLECULAR Year: 2018 Document type: Article Affiliation country: